The healthcare costs associated with comorbidities of refractory asthma and systemic steroid exposure in the UK (Refractory Asthma & Steroid Exposure)

08/11/2013
21/02/2024
EU PAS number:
EUPAS5032
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Refractory Asthma and oral steroid use_OPCRD study protocol_final281013

English (1.09 MB - PDF) View document
Study results
Study report
Other information